2018 – Federal Register Recent Federal Regulation Documents

This document provides notice to customs brokers that the annual user fee that is assessed for each permit held by a broker, whether it may be an individual, partnership, association, or corporation, is due by January 25, 2019. Pursuant to fee adjustments required by the Fixing America's Surface Transportation Act (FAST Act) and CBP regulations, the annual user fee payable in calendar year 2019 will be $144.74.

In accordance with its statutory mandate, the Council is to advise the Secretary of the Department of Health and Human Services and the Director of AHRQ on matters related to AHRQ's conduct of its mission including providing guidance on (A) priorities for health care research, (B) the field of health care research including training needs and information dissemination on health care quality and (C) the role of the Agency in light of private sector activity and opportunities for public private partnerships.

The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) changed the modified adjusted gross income (MAGI) ranges associated with Medicare Part B and Medicare prescription drug coverage premiums for years beginning in 2018. The Bipartisan Budget Act of 2018 (BBA 2018) revised the MAGI ranges again for years beginning with 2019. We consider a beneficiary's MAGI and tax filing status to determine: The percentage of the unsubsidized Medicare Part B premium that the beneficiary must pay; and the percentage of the cost of basic Medicare prescription drug coverage the beneficiary must pay. This final rule makes our regulations consistent with the MAGI ranges specified by MACRA and BBA 2018.

NASA hereby gives notice of its intent to grant a partially exclusive patent license in the United States to practice the inventions described and claimed in U.S. Patent No. 7,655,595 for an invention entitled ``Sol-Gel Based Oxidation Catalyst And Coating System Using Same,'' which issued on February 2, 2010 (NASA Case Number LAR-17154-1); U.S. Patent No. 7,781,366 for an invention entitled ``Sol-Gel Based Oxidation Catalyst And Coating System Using Same,'' which issued on August 24, 2010 (NASA Case Number LAR-17154-2); U.S. Patent No. 6,753,293 for an invention entitled ``Process For Coating Substrates With Catalytic Materials,'' which was issued on June 22, 2004 (NASA Case Number LAR-15851-1-CU); U.S. Patent No. 7,390,768 for an invention entitled ``Stabilized Tin-Oxide-Based Oxidation/Reduction Catalysts'' which issued on June 24, 2008 (NASA Case Number LAR-16307- 1-SB); U.S. Patent No. 7,985,709 for an invention entitled ``Methodology For The Effective Stabilization Of Tin-Oxide-Based Oxidation/Reduction Catalysts'' which was issued on July 26, 2011 (NASA Case Number LAR-16307-2); U.S. Patent No. 7,371,358 for an invention entitled ``Catalyst For Treatment And Control Of Post-Combustion Emissions'' which was issued on May 13, 2008 (NASA Case Number LAR- 16001-1); U.S. Patent No. 9,044,743 for an invention entitled ``Catalyst For Decomposition Of Nitrogen Oxides'' which issued on June 2, 2015 (NASA Case Number LAR-16308-2); and U.S. Patent No. 7,318,915 for an invention entitled ``Oxidation-Reduction Catalyst And Its Process Of Use'' which was issued on January 15, 2008 (NASA Case Number LAR-16390-1), to Sally R, a corporation of the Country of Sweden, having its principal place of business at Hasslogatan 20 Vasteras, Vastmanland Sweden 72131. The fields of use may be limited to Heating Ventilation and Air Conditioning and/or similar fields of use thereto.

The Food and Drug Administration (FDA, Agency, or we) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on individual patient expanded access applications.

As required by the Paperwork Reduction Act of 1995, the Consumer Product Safety Commission (CPSC) announces a submission to the Office of Management and Budget (OMB) requesting an extension of approval for a collection of information related to the CPSC's Standard for Coal and Wood Burning AppliancesNotification of Performance and Technical Data (OMB No. 3041-0040). CPSC previously published a notice announcing the agency's intent to seek this extension. CPSC received no comments in response to that notice.

The Export-Import Bank of the United States (EXIM), as a part of its continuing effort to reduce paperwork and respondent burden, invites the general public and other Federal Agencies to comment on the proposed information collection, as required by the Paperwork Reduction Act of 1995. EXIM plans to invite approximately 150 U.S. exporters and commercial lending institutions that have used EXIM's short-, medium-, and long-term programs over the previous calendar year with an electronic invitation to participate in the online survey. The proposed survey will ask participants to evaluate the competitiveness of EXIM's programs and how the programs compare to those of foreign credit agencies. EXIM will use the responses to develop an analysis of the Bank's competitiveness. The survey can be reviewed at: https://www.exim.gov/sites/default/ files/pub/pending/EXIM_Competitiveness_Report_Survey.pdf.

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled ``Hypertension: Developing Fixed-Combination Drug Products for Treatment.'' The purpose of this guidance is to assist sponsors in the clinical development of fixed-combination drug products for the treatment of hypertension. The guidance focuses on development of two- drug combinations of previously approved drug products. This guidance incorporates the comments received for and finalizes the draft guidance for industry entitled ``Hypertension: Developing Fixed-Dose Combination Drugs for Treatment'' issued on January 26, 2018.

In compliance with the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below.

In accordance with the Paperwork Reduction Act of 1995, ED is proposing an extension of an existing information collection.

In accordance with the procedures governing the application for, and the processing of, special permitsfrom the Department of Transportation's Hazardous Material Regulations, notice is hereby given that the Office of Hazardous Materials Safety has received the application described herein.

In accordance with the procedures governing the application for, and the processing of, special permits from the Department of Transportation's Hazardous Material Regulations, notice is hereby given that the Office of Hazardous Materials Safety has received the application described herein. Each mode of transportation for which a particular special permit is requested is indicated by a number in the ``Nature of Application'' portion of the table below as follows: 1 Motor vehicle, 2Rail freight, 3Cargo vessel, 4Cargo aircraft only, 5Passenger-carrying aircraft.